NumFin

Jeil Pharma Holdings Inc

符号: 002620.KS

KSC

10530

KRW

今天的市场价格

  • -20.3172

    市盈率

  • 0.0956

    PEG比率

  • 161.65B

    MRK市值

  • 0.00%

    DIV收益率

Jeil Pharma Holdings Inc (002620-KS) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 Jeil Pharma Holdings Inc (002620.KS). 的默认数据。公司收入显示 501305.573 M 的平均值，即 0.630 % 增长率。整个期间的平均毛利润为 130332.34 M，即 0.544 %. 平均毛利率为 0.284 %. 公司去年的净收入增长率为 -0.805 %，等于 1.748 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 Jeil Pharma Holdings Inc 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.017. 在流动资产领域，002620.KS 的报告货币为384527.207. 这些资产中的很大一部分，即 59130.986 是现金和短期投资。与去年的数据相比，该部分的变化率为0.107%. 公司的长期投资虽然不是其重点，但以报告货币计算的199929.696（如果有的话）为199929.696。这表明与上一报告期相比，197.875% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 10500. 这一数字表明，-1.000% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 319461.151. 这方面的年同比变化率为 -0.054%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为198695.149，存货估值为 125280.1，商誉估值为 44862.27（如有. 无形资产总额（如果有）按 13093.23 估值. 应付账款和短期债务分别为 154050.03 和 161332.5. 债务总额为173030.54，债务净额为 135991.91. 其他流动负债为 95305.22，加上总负债 477810.92. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

234375.125913153402.747223.7
29961.1
30112
44783.3
13596.5
33171.7
16587.1
12162.5
19030.6
21700.8
22934.2
51259.9
45634.6
19094.8
11309.8

balance-sheet.row.short-term-investments

86457.822092.418643.218642.9
9777.7
8875.1
3685.2
4842.7
3150.8
3098
4096
11360.9
9987.9
273.6
25618.4
17007.7
2469.1
1460.4

balance-sheet.row.net-receivables

782964.19198695.1181304.5167949
180962.6
182090.8
195581.8
18671.5
199125.6
198983.8
182861.6
154971.3
131978.5
137644.3
0
105841.2
87892.5
0

balance-sheet.row.inventory

531549.74125280.1113265.7114242.9
124150.5
96784.3
97562.8
6255.3
80452.5
73623.2
58772.7
63615.1
66945.2
65599.7
57328
46074.5
75603
62496.4

balance-sheet.row.other-current-assets

11507.5714214943.55728.2
0
4633.2
0
0
0
0
0
1037.6
5375.9
31546
131550.5
0
0
94504.3

balance-sheet.row.total-current-assets

1560396.62384527.2352916.4335143.7
335074.2
313620.3
337927.9
38523.4
312749.8
289194.2
253796.8
238654.5
226000.3
257724.2
240138.4
197550.3
182590.4
168310.5

balance-sheet.row.property-plant-equipment-net

921883.08228862.4233120.1212965.1
170478.8
164485.1
135598.4
5060.8
115159.8
92082.5
93288.6
98476
104964.7
65993.6
54457.7
47358.5
46361.3
54193.5

balance-sheet.row.goodwill

265259.9244862.373465.9151801.2
168815.3
168815.3
266347.7
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

48297.9413093.29472.33781.3
4117.8
4350.1
4372.9
16.2
4373
4813
5272.4
4003.5
3841.4
3958.6
612.1
376.4
235.5
207.2

balance-sheet.row.goodwill-and-intangible-assets

313557.8657955.582938.2155582.5
172933
173165.3
270720.6
16.2
4373
4813
5272.4
4003.5
3841.4
3958.6
612.1
376.4
235.5
207.2

balance-sheet.row.long-term-investments

389896.62199929.767118.860379.6
60218.4
56221.6
57202
133203.2
45088.9
43894
39995.2
33837.7
36009.6
45855.6
16240.1
22867.1
30448.4
24918.6

balance-sheet.row.tax-assets

-64449.595448.7188.51451.9
3457.2
2393
1049.9
387.5
14613.6
0
0
21125.8
19949.1
10431.1
1004.2
21896.1
747.5
511.3

balance-sheet.row.other-non-current-assets

470872.573273.5129395.1126898.6
145233.5
136589.2
117587
20396.3
0
15182.4
17214.2
0
0
167.9
32496.4
0
6928.7
6314.7

balance-sheet.row.total-non-current-assets

2031760.54495469.8512760.6557277.7
552320.9
532854.2
582157.9
159064.1
179235.2
155971.9
155770.4
157442.9
164764.8
126406.8
104810.5
92498.1
84721.4
86145.2

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

3592157.16879997865677892421.4
887395.1
846474.5
920085.8
197587.5
491985
445166.1
409567.2
396097.4
390765.2
384131
344949
290048.4
267311.8
254455.7

balance-sheet.row.account-payables

636258.45154050162967.4159388.3
149264.5
157545.2
151126.8
5000.2
140161.2
129398.5
107425.9
108142.9
89669.2
101499.9
87013.4
59554
66381.9
69843.8

balance-sheet.row.short-term-debt

600673.06161332.5119087.394964.5
137208.9
108492.9
95171.5
678.6
29457.8
21345.5
8627.1
6000
16376.5
6000
6000
6000
11000
6085

balance-sheet.row.tax-payables

3382.6774.71159.8684.8
4736.9
5087.5
1844.8
908.6
2647.1
4839.7
7067.6
305.3
307.5
1750.2
5157.2
9892.1
5931.2
6883.4

balance-sheet.row.long-term-debt-total

49892.41105001747720107.5
12584.7
14102.2
19906.3
0
27500
5000
7000
8000
8000
0
0
0
0
60

Deferred Revenue Non Current

9246.161198036229.2
16382.8
7243.1
5959.1
0
0
0
0
0
8737.1
0
0
0
0
8579.1

balance-sheet.row.deferred-tax-liabilities-non-current

145216.43---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

205023.8695305.27466217971.9
15149.1
14367.4
32833.6
0
0
0
0
0
0
0
0
15261.3
0
15954.7

balance-sheet.row.total-non-current-liabilities

262882.1265175.187379.894084.1
60793.4
49608.6
49532.8
11781.4
46350.9
28747.7
31235.4
28526.8
28116.5
22157.9
19561
15678.1
15106
15922.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

6892.9511981869.22383.2
790.7
320.9
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

1882055.08477810.9445884.6392107.7
388110.9
363437.5
330509.5
27149.1
239905.3
203777.7
174354.3
158494.9
149359.8
152735.6
137183
106385.5
111982.7
114689.2

balance-sheet.row.preferred-stock

43492.24000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

31946.717986.77986.77986.7
7986.7
7986.7
7986.7
2172.8
7425
7425
7425
7425
7425
7425
7425
7425
7425
7425

balance-sheet.row.retained-earnings

309763.33-14357.598244.6172151.3
175785.2
163566.9
257168.4
745147.4
226724.6
219963.5
212703
214666
215702.9
204846
179217.7
155053.2
127838.4
111670.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

477369.96152732.4226471226109.7
220488.3
252482.5
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

498974.16173099.55062.45482.9
3191.6
-30554.3
225178.7
-580584.4
14790.9
14000
15084.9
15511.4
18277.5
19124.5
21123.2
21184.7
20065.7
20671.2

balance-sheet.row.total-stockholders-equity

1361546.4319461.2337764.7411730.5
407451.8
393481.8
490333.8
166735.7
248940.6
241388.5
235212.9
237602.5
241405.3
231395.4
207765.9
183662.9
155329.1
139766.5

balance-sheet.row.total-liabilities-and-stockholders-equity

3592157.16879997865677892421.4
887395.1
846474.5
920085.8
197587.5
491985
445166.1
409567.2
396097.4
390765.2
384131
344949
290048.4
267311.8
254455.7

balance-sheet.row.minority-interest

348555.6782724.982027.888583.2
91832.4
89555.3
99242.5
3702.8
3139.2
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

1710102.08402186.1419792.5500313.7
499284.2
483037.1
589576.3
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

3592157.16---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

476354.42222022.185761.979022.5
69996.2
65096.6
60887.3
138045.9
48239.6
46992
44091.2
45198.6
45997.5
46129.2
41858.5
39874.8
32917.5
26379

balance-sheet.row.total-debt

651763.51173030.5136564.4115072
149793.6
122595.1
115077.8
678.6
56957.8
26345.5
15627.1
14000
24376.5
6000
6000
6000
11000
6145

balance-sheet.row.net-debt

503846.19135991.9101804.986491.2
129610.2
101358.1
73979.7
-8075.3
26936.9
12856.4
7560.6
6330.3
12663.6
-16660.6
-19641.5
-22627
-5625.7
-3704.4

现金流量表

在 Jeil Pharma Holdings Inc 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 1.000 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-13425021048.000. 与上一年相比， -0.236 发生了变化. 在同一时期，公司记录了 12556.11, 93.81 和 -22634.4，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-1133.88 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 44384.34，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

-11642.57-16249.7-83145-12870
14941.1
-95854
7301.6
519341.5
7890.3
9761.4
2095.5
2098
13628
32819.8
25470.2
27998.3
17534.8
13674

cash-flows.row.depreciation-and-amortization

12556.1112556.110905.18983.2
8650.7
7782.7
1658.6
3716.6
7680.3
8464.7
8544.4
8370
6539.1
4475.3
3747.4
3031.5
3611.1
4484.6

cash-flows.row.deferred-income-tax

-8558.55-606320-664
-6023.7
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

578.03578472.5163.2
80
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-28544.09-28544.1-22115.214405.2
-44673.8
14692.4
-9247.8
-4682
-5565.9
-15941.5
-23560.2
253.8
-18816.7
-6033.4
-11839.5
8047
-17722.5
-829

cash-flows.row.account-receivables

-12922.7-12922.7-14120.28024.7
4993.4
8298.5
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-12170.48-12170.51347.39341.5
-28712.4
588.9
-7300.7
-7071.9
-6761
-14818.1
4757.5
3330.1
-1345.5
-9503.7
-11253.5
29528.5
-13106.6
-11221.8

cash-flows.row.account-payables

-9848.6-9848.63357.510023.5
-8555
6386.6
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

6397.696397.7-12699.8-12984.4
-12399.7
-581.5
-1947.1
2389.9
1195.1
-1123.4
-28317.8
-3076.3
-17471.2
3470.3
-586.1
-21481.6
-4615.9
10392.8

cash-flows.row.other-non-cash-items

31195.4487876.173080.53385.4
3354.2
98594.6
-3145.2
-512453
1350.4
458.6
9137.3
2193.9
-5293.2
-5596.1
2361.2
1329.1
-3556
-1657.6

cash-flows.row.net-cash-provided-by-operating-activities

-4415.63000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-9909.58-9836.6-21410-23736.1
-10267.4
-1659.7
-1437.6
-2971.3
-30326.5
-7052.9
-4793
-2396.1
-47550.8
-24709.3
-11082.5
-5244.3
-2806.6
-5666.5

cash-flows.row.acquisitions-net

87.6487.624-1500
6931
-33138.8
17
0
-500
882.6
-437.1
-441.6
1219.1
0
-273.8
-173.4
6945.8
-67.6

cash-flows.row.purchases-of-investments

-3775.84-3769.8-0.3-10005.3
-22190.8
-28492.8
-7897.3
-2091.9
-3489.8
-5106.3
-2973.8
-1268.8
-9655.2
0
-48331.7
-19371.4
-2618.7
-1518.9

cash-flows.row.sales-maturities-of-investments

00169.7999.5
20055
22098.2
8129.6
0
3049.1
6127.6
10111.2
769.2
33728.2
134.8
39697.2
2469.1
1445.8
1610.8

cash-flows.row.other-investing-activites

172.7693.83652.941567.1
3865.8
345.8
-45762.9
1269.4
1390.9
1149.8
917.2
664.7
-48
-2213.9
-1428.4
-301.3
454.4
-631.5

cash-flows.row.net-cash-used-for-investing-activites

-13425.02-13425-17563.77325.1
-1606.4
-40847.3
-46951.2
-3793.8
-29876.4
-3999.2
2824.5
-2672.6
-22306.6
-26788.4
-21419.1
-22621.2
3420.7
-6273.7

cash-flows.row.debt-repayment

-31854.19-22634.4-5156.3-6125
-11125
-77073.3
0
-9704.8
-2001
-3000
0
-12376.5
-10422.5
0
0
-5000
-145
-6000

cash-flows.row.common-stock-issued

0007497.6
37.9
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

00-397-31210.2
37882.1
0
0
0
0
-3124.5
-28.4
-3017.3
-1399
-461.2
0
0
0
0

cash-flows.row.dividends-paid

-362-1133.9-1474.9-1590
-1586.2
-1520.4
-223.3
-891.2
-764.2
-772.8
-515.5
-786.8
-1173.6
-1308.7
-1305.7
-783.4
-1366.8
-1302.7

cash-flows.row.other-financing-activites

54328.1344384.351942.119190
-314.9
74705.9
77899.2
-13204.3
37613.2
13718.4
1627.1
2000
28799
0
0
0
5000
0

cash-flows.row.net-cash-used-provided-by-financing-activities

20616.0720616.144914-12237.6
24894
-3887.9
77675.9
-23800.3
34848
6821.1
1083.2
-14180.6
15803.9
-1769.8
-1305.7
-5783.4
3488.2
-7302.7

cash-flows.row.effect-of-forex-changes-on-cash

-496.29-496.3-369.4-93.2
-669.7
-341.7
6.4
-64.7
205.2
-142.4
272.3
-105.7
-502.2
-88.2
0
0
0
0

cash-flows.row.net-change-in-cash

2279.122279.16178.78397.4
-1053.6
-19861.2
32344.3
-21267.1
16531.8
5422.6
396.8
-4043.2
-10947.7
-2980.9
-2985.5
12001.3
6776.3
2095.6

cash-flows.row.cash-at-end-of-period

147917.3237038.634759.528580.8
20183.4
21237
41098.1
8753.8
30020.9
13489.1
8066.5
7669.7
11712.9
22660.6
25641.5
28627
16625.7
9849.4

cash-flows.row.cash-at-beginning-of-period

145638.234759.528580.820183.4
21237
41098.1
8753.8
30020.9
13489.1
8066.5
7669.7
11712.9
22660.6
25641.5
28627
16625.7
9849.4
7753.8

cash-flows.row.operating-cash-flow

-4415.63-4415.6-20802.213403.1
-23671.5
25215.8
-3432.8
5923.1
11355.1
2743.2
-3783.1
12915.7
-3942.8
25665.6
19739.3
40405.9
-132.6
15672

cash-flows.row.capital-expenditure

-9909.58-9836.6-21410-23736.1
-10267.4
-1659.7
-1437.6
-2971.3
-30326.5
-7052.9
-4793
-2396.1
-47550.8
-24709.3
-11082.5
-5244.3
-2806.6
-5666.5

cash-flows.row.free-cash-flow

-14325.21-14252.3-42212.2-10333.1
-33938.9
23556
-4870.4
2951.9
-18971.4
-4309.7
-8576.1
10519.6
-51493.6
956.3
8656.9
35161.6
-2939.2
10005.5

利润表行

Jeil Pharma Holdings Inc 的收入与上期相比变化了 0.014%。据报告, 002620.KS 的毛利润为 201821.98。该公司的营业费用为 190231.19，与上年相比变化了 1.170%. 折旧和摊销费用为 12556.11，与上一会计期间相比变化了 -1.199%. 营业费用报告为 190231.19，显示1.170% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长3.758%. 营业收入为 11590.8，与上年相比变化了-2.536%. 净利润的变化率为 -0.805%。去年的净收入为-16249.74.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

801550.85794713.6792964.7762568.1
761996.8
731140.4
142736.3
44440.6
617279.9
594715.7
512736.2
451968.2
426819.2
462853.4
431307
369486.9
319439.9
305027.9

income-statement-row.row.cost-of-revenue

590068.68592891.6612481.6582061.3
570757.4
549162.6
86278.9
23133.4
482154.8
454500.3
383860.8
342551.6
319038.6
329680
297369.6
248373.5
224114
208135

income-statement-row.row.gross-profit

211482.17201822180483.1180506.8
191239.3
181977.8
56457.5
21307.2
135125.1
140215.4
128875.4
109416.7
107780.6
133173.4
133937.4
121113.4
95325.8
96892.9

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

45642.2---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

43332.62---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

37213.16---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

20406.324200.967032.463480.2
63837.1
60353.4
1187.1
35.8
1731.4
1606.9
1683.3
1413.1
6504.8
1027.8
-379.1
701.7
813.2
-1130.4

income-statement-row.row.operating-expenses

193054.13190231.2188031.1189481.7
168758.1
172971
45508.1
21015.1
125771.9
127067
120324.2
108043.9
101460.4
101671.1
92771.6
82572.4
79649.4
79101.2

income-statement-row.row.cost-and-expenses

783122.82783122.8800512.7771542.9
739515.6
722133.6
131786.9
44148.4
607926.7
581567.2
504185
450595.5
420499
431351
390141.2
330945.9
303763.4
287236.2

income-statement-row.row.interest-income

1731.421731.4499.5247.7
171.1
336.7
147.6
82.4
41.7
152.2
243.4
371.7
740.5
1485
1707.4
1105.2
720.2
612.9

income-statement-row.row.interest-expense

10672.1110672.15952.33288.7
3194.1
2858.2
1017
18.7
775.9
572.8
658.8
753.7
753.3
319.8
294.3
621.3
615.2
634.7

income-statement-row.row.selling-and-marketing-expenses

37213.16---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-34901.84-34901.8-76312.7-7682.1
-3860.7
-100339.4
-1161.4
3245.1
4449.2
2901.2
3283.1
725.2
7307.8
5808.2
4384.1
5431.8
11010.8
7326.4

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

20406.324200.967032.463480.2
63837.1
60353.4
1187.1
35.8
1731.4
1606.9
1683.3
1413.1
6504.8
1027.8
-379.1
701.7
813.2
-1130.4

income-statement-row.row.total-operating-expenses

-34901.84-34901.8-76312.7-7682.1
-3860.7
-100339.4
-1161.4
3245.1
4449.2
2901.2
3283.1
725.2
7307.8
5808.2
4384.1
5431.8
11010.8
7326.4

income-statement-row.row.interest-expense

10672.1110672.15952.33288.7
3194.1
2858.2
1017
18.7
775.9
572.8
658.8
753.7
753.3
319.8
294.3
621.3
615.2
634.7

income-statement-row.row.depreciation-and-amortization

15380.4812556.1-63218.78983.2
8650.7
7782.7
1658.6
3716.6
7680.3
8464.7
8544.4
8370
6539.1
4475.3
3747.4
3031.5
3611.1
4484.6

income-statement-row.row.ebitda-caps

34548.17---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

18428.0411590.8-75481552.9
34682.4
17739.8
10949.4
292.2
9353.2
13148.4
8551.2
1372.8
6320.3
32819.8
41165.9
38541
15676.5
17791.7

income-statement-row.row.income-before-tax

-16473.8-23311-83860.6-6129.2
30821.7
-82599.7
9788
3537.3
13802.4
16049.7
11834.3
2098
13628
37310.5
45550
43972.8
26687.2
25118

income-statement-row.row.income-tax-expense

-740.82-740.8-715.66740.8
15880.6
13254.3
2486.3
-489.5
5912.1
6288.3
9738.9
1613.6
2456.2
10295.7
20079.8
15974.6
9152.4
11444

income-statement-row.row.net-income

-7978.87-16249.7-83145-12870
11431.1
-95854
7070
518816.6
7890.3
9761.4
2095.5
484.4
11171.8
27014.8
25470.2
27998.3
17534.8
13674
类似股票
您可能还对以下内容感兴趣：
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
TLLTF
TILT Holdings Inc..
0.031 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
566.6 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
600750.SS
Jiang Zhong Pharmaceutical Co.,Ltd.
26.66 CNY
SHH
2196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd..
12.48 HKD
HKSE
002693.SZ
Hainan Shuangcheng Pharmaceuticals Co., Ltd..
5.26 CNY
SHZ
ERIS.NS
Eris Lifesciences Limited.
895.95 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX

常见问题

什么是 Jeil Pharma Holdings Inc (002620.KS) 总资产是多少？

Jeil Pharma Holdings Inc (002620.KS) 总资产为 879996990707.000.

什么是企业年收入？

年收入为 395204780875.000.

企业利润率是多少？

公司利润率为 0.264.

什么是公司自由现金流？

自由现金流为 -933.170.

什么是企业净利润率？

净利润率为 -0.010.

企业总收入是多少？

总收入为 0.023.

什么是 Jeil Pharma Holdings Inc (002620.KS) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 -16249744239.000.

公司总债务是多少？

债务总额为 173030541501.000.

营业费用是多少？

运营支出为 190231187725.000.

公司现金是多少？

企业现金为 37038628042.000.